Bloxiverz (Avadel Legacy Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Bloxiverz drug offered from Avadel Legacy Pharmaceuticals, LLC. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avadel Legacy Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | Neostigmine Methylsulfate |
| SUBSTANCE NAME: | NEOSTIGMINE METHYLSULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-07-24 |
| END MARKETING DATE: | 0000-00-00 |
Bloxiverz HUMAN PRESCRIPTION DRUG Details:
| Item Description | Bloxiverz from Avadel Legacy Pharmaceuticals, LLC |
| LABELER NAME: | Avadel Legacy Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/mL) |
| START MARKETING DATE: | 2013-07-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76014-002_3e14fe43-ec4e-440b-afdc-8d1c74698664 |
| PRODUCT NDC: | 76014-002 |
| APPLICATION NUMBER: | NDA204078 |
Other NEOSTIGMINE METHYLSULFATE Pharmaceutical Manufacturers / Labelers:
